A harm reduction model to assess the impact of new treatments for pain over standard of care among patients with osteoarthritis

BACKGROUND: Osteoarthritis (OA) affects millions of adults in the United States and can result in substantial pain, functional impairment, and significant clinical and economic burden. To manage chronic pain associated with OA, treatment guidelines recommend a variety of pharmacologic treatments, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Silverman, Stuart, Schepman, Patricia, Rice, J Bradford, Robinson, Rebecca L, White, Alan G, Fernan, Catherine, Beck, Craig G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391000/
https://www.ncbi.nlm.nih.gov/pubmed/34818088
http://dx.doi.org/10.18553/jmcp.2021.27.12.1652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391000/
https://www.ncbi.nlm.nih.gov/pubmed/34818088
http://dx.doi.org/10.18553/jmcp.2021.27.12.1652

Ejemplares similares